Literature DB >> 18566995

Expression and function of fatty acid amide hydrolase in prostate cancer.

Michael P Endsley1, Rebecca Thill, Iffat Choudhry, Carol L Williams, Andre Kajdacsy-Balla, William B Campbell, Kasem Nithipatikom.   

Abstract

The hydrolysis of endocannabinoids has profound effects on the function of the endocannabinoid signaling system in the regulation of prostate carcinoma cells. Prostate carcinoma cells exhibit a wide range of hydrolysis activity for 2-arachidonoylglycerol (2-AG), the major endocannabinoid. However, enzyme(s) responsible for 2-AG hydrolysis and their functions in prostate cancer have not been characterized. In this study, we demonstrated that fatty acid amide hydrolase (FAAH) was differentially expressed in normal and prostate carcinoma cells. In PC-3 cells, overexpression of FAAH resulted in increased FAAH protein, 2-AG hydrolysis, cell invasion and cell migration. Conversely, small-interfering RNA (siRNA) knockdown of FAAH in LNCaP cells decreased FAAH protein, 2-AG hydrolysis and cell invasion. Furthermore, CAY10401, a FAAH inhibitor, decreased cell invasion and it enhanced the reduction of invasion in FAAH siRNA-transfected LNCaP cells. Immunohistochemistry staining of commercial tissue microarrays (TMAs) demonstrated FAAH staining in 109 of 157 cores of prostate adenocarcinomas but weak staining in 1 of 8 cores of normal prostate tissues. These results suggest that FAAH regulates 2-AG hydrolysis and invasion of prostate carcinoma cells and is potentially involved in prostate tumorigenesis. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566995      PMCID: PMC2548421          DOI: 10.1002/ijc.23674

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

2.  Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.

Authors:  J Ghosh; C E Myers
Journal:  Biochem Biophys Res Commun       Date:  1997-06-18       Impact factor: 3.575

3.  Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages.

Authors:  V Di Marzo; T Bisogno; L De Petrocellis; D Melck; P Orlando; J A Wagner; G Kunos
Journal:  Eur J Biochem       Date:  1999-08

4.  Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.

Authors:  S K Goparaju; N Ueda; H Yamaguchi; S Yamamoto
Journal:  FEBS Lett       Date:  1998-01-23       Impact factor: 4.124

5.  12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha.

Authors:  B Liu; R J Maher; J P De Jonckheere; R U Popat; S Stojakovic; Y A Hannun; A T Porter; K V Honn
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

6.  The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.

Authors:  V Di Marzo; T Bisogno; T Sugiura; D Melck; L De Petrocellis
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

7.  Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide.

Authors:  N Ueda; Y Kurahashi; S Yamamoto; T Tokunaga
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

8.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

9.  Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells.

Authors:  Giulio G Muccioli; Cong Xu; Emma Odah; Eiron Cudaback; Jose Antonio Cisneros; Didier M Lambert; María Luz López Rodríguez; Sandra Bajjalieh; Nephi Stella
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

10.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

View more
  37 in total

1.  N-acyl taurines are anti-proliferative in prostate cancer cells.

Authors:  Vicky Chatzakos; Katharina Slätis; Tatjana Djureinovic; Thomas Helleday; Mary C Hunt
Journal:  Lipids       Date:  2011-12-11       Impact factor: 1.880

2.  Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Authors:  Paula Vainio; Santosh Gupta; Kirsi Ketola; Tuomas Mirtti; John-Patrick Mpindi; Pekka Kohonen; Vidal Fey; Merja Perälä; Frank Smit; Gerald Verhaegh; Jack Schalken; Kalle A Alanen; Olli Kallioniemi; Kristiina Iljin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Kasem Nithipatikom; Michael P Endsley; Adam W Pfeiffer; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2014-06-23       Impact factor: 5.922

4.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

Review 5.  Cannabinoids, endocannabinoids, and cancer.

Authors:  Daniel J Hermanson; Lawrence J Marnett
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 6.  The endocannabinoid system in prostate cancer.

Authors:  Inés Díaz-Laviada
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

7.  Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

Authors:  Daniel K Nomura; Donald P Lombardi; Jae Won Chang; Sherry Niessen; Anna M Ward; Jonathan Z Long; Heather H Hoover; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2011-07-29

Review 8.  The endocannabinoid system and cancer: therapeutic implication.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

9.  Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Michael P Endsley; Jeffrey E Woodliff; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-12-15       Impact factor: 3.072

10.  Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Ana Doris Gomez-Granados; Alan T Tang; Adam W Pfeiffer; Carol L Williams; William B Campbell
Journal:  Endocrinology       Date:  2011-11-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.